03:58:23 EDT Mon 23 Mar 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 21 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-03-23 03:31U:NBISNews ReleaseNebius Group Announces Closing of Private Offering of Convertible Senior Notes, With Aggregate Gross Proceeds of Approximately $4.3 Billion
2026-03-23 03:20U:IHGNews ReleaseInterContinental Hotels Group PLC Announces Transaction in Own Shares - March 23
2026-03-23 03:20U:ICHGFNews ReleaseInterContinental Hotels Group PLC Announces Transaction in Own Shares - March 23
2026-03-23 03:20U:EPMLFNews ReleaseEmpire Metals Limited Announces Final Results
2026-03-23 03:10U:EVONews ReleaseJust - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
2026-03-23 03:00U:CMCLNews ReleaseABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
2026-03-23 02:30U:ONWRYNews ReleaseONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
2026-03-23 02:00U:STMNews ReleaseSTMicroelectronics China-manufactured STM32 microcontrollers begin volume production
2026-03-22 23:52U:AIXCNews ReleaseAIxCrypto Acknowledges Conclusion of SEC Investigation with no Enforcement Action Involving majority controlling stockholder, Faraday Future and Reaffirms Strategic Focus
2026-03-22 22:00U:WTWNews ReleaseWillis partners with Circle Asia to launch Asia's first insurance facility for collectors and galleries
2026-03-22 21:56U:RRSXFNews ReleaseMagnetite Mines Ltd (RRSXF) GREEN IRON SA Advances Port Pirie Iron Ore Export Concept
2026-03-22 20:00U:HCMNews ReleaseHUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China
2026-03-22 19:52U:APGENews ReleaseApogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026
2026-03-22 18:30U:VIRTNews ReleaseNissay Asset Management Adopts Triton
2026-03-22 18:10U:ELEKNews ReleaseElektros Inc. Marks Global World Water Day With Initiative To Deliver Clean Drinking Water To Sierra Leone Communities
2026-03-22 18:00U:SGLJFNews ReleaseStrauss Group Announces Timing of Fourth Quarter and FY 2025 Earnings Release and Webcast
2026-03-22 16:30U:FFAINews ReleaseFaraday Future Announces that the SEC has Ended its Years-Long Investigation with No Enforcement or Other Action Against the Company or Related Persons
2026-03-22 12:00U:SPGINews ReleaseLeaders and Experts from Amazon Web Services, Google, Microsoft, NVIDIA, Meta, Dell, Applied Materials and AMD Headline Technology and Innovation Programming at CERAWeek by S&P Global, March 23-27 in Houston
2026-03-22 10:00U:IDYANews ReleaseIDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
2026-03-22 09:01U:HMRFFNews ReleaseHomerun Resources Inc. to Participate in Water Tower Research Fireside Chat on March 24, 2026
2026-03-22 08:17U:SNOWNews ReleaseSNOW DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Snowflake (SNOW) Investors of Securities Class Action Deadline on April 27, 2026